Optics.org
daily coverage of the optics & photonics industry and the markets that it serves
Featured Showcases
Photonics West Showcase
News
Menu
Carolyn Cross
Carolyn Cross of Ondine Biomedical believes that PDT should be championed for certain treatments, in the absence of better alternatives. Credit: Ondine Biomedical.
© 2023 SPIE Europe
Top of Page